Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy

Lasers in Medical Science

Volumn 19, Issue 3, 2004, Pages 139-149

  Juzeniene, Asta ^a   Juzenas, Petras ^a   Ma, Li Wei ^a   Iani, Vladimir ^a   Moan, Johan ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Methyl 5 aminolevulinate; Photodynamic therapy; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGY; BLEACHING; DIODE; FEMALE; HEATING; HUMAN; LIGHT; MOUSE; NONHUMAN; PARAMETER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; SKIN;

ADENOCARCINOMA; AMINOLEVULINIC ACID; ANIMALS; COLONIC NEOPLASMS; FEMALE; HUMANS; LUMINESCENT MEASUREMENTS; MICE; MICE, INBRED BALB C; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN; TUMOR CELLS, CULTURED;

EID: 12944249210     PISSN: 02688921     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10103-004-0314-x     Document Type: Article

References (66)

1. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90:889-905
2. Kalka K, Merk H, Mukhtar H (2000) Photodynamic therapy in dermatology. J Am Acad Dermatol 42:389-413
3. Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3:380-387
4. Zeitouni NC, Shieh S, Oseroff AR (2001) Laser and photodynamic therapy in the management of cutaneous malignancies. Clin Dermatol 19:329-338
5. Azizkhan RG (2003) Laser surgery: new applications for pediatric skin and airway lesions. Curr Opin Pediatr 15:243-247
6. Al Buainian H, Verhaeghe E, Dierckxsens L, Naeyaert JM (2003) Early treatment of hemangiomas with lasers. A review. Dermatology 206:370-373
7. Papadavid E, Katsambas A (2003) Lasers for facial rejuvenation: a review. Int J Dermatol 42:480-487
8. Goldberg DJ (2002) Laser hair removal. Dermatol Clin 20:561-567
9. Szeimies RM, Hein R, Baumler W, Heine A, Landthaler M (1994) A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. Acta Derm Venereol 74:117-119
10. Brancaleon L, Moseley H (2002) Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci 17:173-186
11. Whitehurst C, Byrne K, Moore JV (1993) Development of an alternative light source to lasers for photodynamic therapy: 1. Comparative in vitro dose response characteristics. Lasers Med Sci 8:259-267
12. Whitehurst C, Humphries JD, Moore JV (1995) Development of an alternative light source to lasers for photodynamic therapy: 2. Comparative in vivo tumour response characteristics. Lasers Med Sci 10:121-126
13. Morton CA, Whitehurst C, Moseley H, Moore JV, MacKie RM (1995) Development of an alternative light source to lasers for photodynamic therapy: 3. Clinical evaluation in the treatment of pre-malignant non-melanoma skin cancer. Lasers Med Sci 10:165-171
14. Moseley H (1996) Total effective fluence: a useful concept in photodynamic therapy. Lasers Med Sci 11:139-143
15. Soler AM, Angell-Petersen E, Warloe T, Tausjo J, Steen HB, Moan J, Giercksky KE (2000) Photodynamic therapy of superficial basal cell carcinoma with 5- aminolevulinic acid with dimethylsulfoxide and ethylenediaminetetraacetic acid: a comparison of two light sources. Photochem Photobiol 71:724-729
16. Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson SH (2003) Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 19:134-141
17. Moan J, Peng Q, Evensen JF, Berg K, Western A, Rimington C (1987) Photosensitizing efficiencies, tumor- and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol 46:713-721
18. Georgakoudi I, Nichols MG, Foster TH (1997) The mechanism of photofrin photobleaching and its consequences for photodynamic dosimetry. Photochem Photobiol 65:135-144
19. Mang TS, Dougherty TJ, Potter WR, Boyle DG, Somer S, Moan J (1987) Photobleaching of porphyrins used in photodynamic therapy and implications for therapy. Photochem Photobiol 45:501-506
20. Robinson DJ, de Bruijn HS, van der Veen N, Stringer MR, Brown SB, Star WM (1999) Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin. Photochem Photobiol 69:61-70
21. Rotomskis R, Bagdonas S, Streckyte G, Wendenburg R, Dietel W, Didziapetriene J, Ibelhauptaite A, Staciokiene L (1998) Phototransformation of sensitizers: 3. Implications for clinical dosimetry. Lasers Med Sci 13:271-278
22. Svaasand LO, Wyss P, Wyss MT, Tadir Y, Tromberg BJ, Berns MW (1996) Dosimetry model for photodynamic therapy with topically administered photosensitizers. Lasers Surg Med 18:139-149
23. Wilson BC, Patterson MS, Lilge L (1997) Implicit and explicit dosimetry in photodynamic therapy: a new paradigm. Lasers Med Sci 12:182-199
24. Longnecker DE, Harris PD (1980) Microcirculatory actions of general anesthetics. Fed Proc 39:1580-1583
25. Juzeniene A, Juzenas P, Kaalhus O, Iani V, Moan J (2002) Temperature effect on accumulation of protoporphyrin IX after topical application of 5-aminolevulinic acid and its methylester and hexylester derivatives in normal mouse skin. Photochem Photobiol 76:452-456
26. Jensen EW, Nygaard M, Henneberg SW (1998) On-line analysis of middle latency auditory evoked potentials (MLAEP) for monitoring depth of anaesthesia in laboratory rats. Med Eng Phys 20:722-728
27. Noguchi P, Wallace R, Johnson J, Earley EM, O'Brien S, Ferrone S, Pellegrino MA, Milstien J, Needy C, Browne W, Petricciani J (1979) Characterization of the WIDR: a human colon carcinoma cell line. In Vitro 15:401-408
28. Juzeniene A, Ma LW, Juzenas P, Iani V, Lange N, Moan J (2002) Production of protoporphyrin IX from 5-aminolevulinic acid and two of its esters in cells in vitro and tissues in vivo. Cell Mol Biol 48:911-916
29. Juzeniene A, Juzenas P, Iani V, Moan J (2002) Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model. Photochem Photobiol 76:329-334
30. Moan J, Peng Q, Sorensen R, Iani V, Nesland JM (1998) The biophysical foundations of photodynamic therapy. Endoscopy 30:387-391
31. Juzenas P, Juzeniene A, Kaalhus O, Iani V, Moan J (2002) Noninvasive fluorescence excitation spectroscopy during application of 5-aminolevulinic acid in vivo. Photochem Photobiol Sci 1:745-748
32. Moan J, Kessel D (1988) Photoproducts formed from photofrin II in cells. J Photochem Photobiol B 1:429-436
33. Svaasand LO (1985) Photodynamic and photohyperthermic response of malignant tumors. Med Phys 12:455-461
34. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM (1997) 5-aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79:2282-2308
35. Robinson DJ, de Bruijn HS, de Wolf WJ, Sterenborg HJ, Star WM (2000) Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect. Photochem Photobiol 72:794-802
36. Moan J (1984) The photochemical yield of singlet oxygen from porphyrins in different states of aggregation. Photochem Photobiol 39:445-449
37. Reddi E, Jori G (1988) Steady state and time-resolved spectroscopic studies of photodynamic sensitizers; porphyrins and phthalocyanines. Rev Chem Intermed 10:241-268
38. Negri RM, Zalts A, San Roman EA, Aramendia PF, Braslavsky SE (1991) Carboxylated zinc-phthalocyanine, influence of dimerization on the spectroscopic properties. An absorption, emission and thermal lensing study. Photochem Photobiol 53:317-322
39. Juzenas P, Sharfaei S, Moan J, Bissonnette R (2002) Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester. J Photochem Photobiol B 67:11-17
40. Juzenas P, Iani V, Bagdonas S, Rotomskis R, Moan J (2001) Fluorescence spectroscopy of normal mouse skin exposed to 5-aminolaevulinic acid and red light. J Photochem Photobiol B 61:78-86
41. Robinson DJ, de Bruijn HS, van der Veen N, Stringer MR, Brown SB, Star WM (1998) Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol 67:140-149
42. Finlay JC, Conover DL, Hull EL, Foster TH (2001) Porphyrin bleaching and PDT-induced spectral changes are irradiance dependent in ALA-sensitized normal rat skin in vivo. Photochem Photobiol 73:54-63
43. Moan J, Juzenas P, Bagdonas S (2000) Degradation and transformation of photosensitizers during light exposure. In: Pandalai SG (ed) Recent Research Developments in Photochemistry and Photobiology, Transworld Research Network Trivandrum, pp 121-132
44. Konig K, Felsmann A, Dietel W, Boschmann M (1990) Photodynamic activity of HpD-photoproducts. Studia Biophys 138:219-228
45. Giniunas L, Rotomskis R, Smilgevicius V, Piskarskas AP, Didziapietriene J, Bloznelyte L, Griciute L (1991) Activity of haematoporphyrin derivative photoproduct in photodynamic therapy in vivo. Lasers Med Sci 6:425-428
46. Konig K, Schneckenburger H, Ruck A, Steiner R (1993) In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins. J Photochem Photobiol B 18:287-290
47. Wessels JM, Sroka R, Heil P, Seidlitz HK (1993) Photodegradation of protoporphyrin-dimethylester in solution and in organized environments. Int J Radiat Biol 64:475-484
48. Ma L, Bagdonas S, Moan J (2001) The photosensitizing effect of the photoproduct of protoporphyrin IX. J Photochem Photobiol B 60:108-113
49. Bonnett R, Martinez G (2001) Photobleaching of sensitisers used in photodynamic therapy. Tetrahedron 57:9513-9547
50. Bagdonas S, Ma LW, Iani V, Rotomskis R, Juzenas P, Moan J (2000) Phototransformations of 5-aminolevulinic acid-induced protoporphyrin IX in vitro: a spectroscopic study. Photochem Photobiol 72:186-192
51. Moan J (1986) Effect of bleaching of porphyrin sensitizers during photodynamic therapy. Cancer Lett 33:45-53
52. Brun A, Western A, Malik Z, Sandberg S (1990) Erythropoietic protoporphyria: photodynamic transfer of protoporphyrin from intact erythrocytes to other cells. Photochem Photobiol 51:573-577
53. Moan J, Streckyte G, Bagdonas S, Bech O, Berg K (1997) Photobleaching of protoporphyrin IX in cells incubated with 5-aminolevulinic acid. Int J Cancer 70:90-97
54. Krieg M, Whitten DG (1984) Self-sensitized photo-oxidation of protoporphyrin iX and related porphyrins in erythrocyte ghosts and microemulsions: a novel photo-oxidation pathway involving singlet oxygen. J Photochem 25:235-252
55. Stender IM, Na R, Fogh H, Gluud C, Wulf HC (2000) Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet 355:963-966
56. Lui H, Anderson RR (1993) Photodynamic therapy in dermatology: recent developments. Dermatol Clin 11:1-13
57. Grapengiesser S, Ericson M, Gudmundsson F, Larko O, Rosen A, Wennberg AM (2002) Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 27:493-497
58. Fijan S, Honigsmann H, Ortel B (1995) Photodynamic therapy of epithelial skin tumours using δ5-aminolaevulinic acid and desferrioxamine. Br J Dermatol 133:282-288
59. Fuchs J, Thiele J (2003) The role of oxygen in cutaneous photodynamic therapy. Free Radic Biol Med 24:835-847
60. Warloe T, Peng Q, Moan J, Qvist HL, Giercksky KE (1992) Photochemotherapy of multiple basal cell carcinoma with endogenous porphyrins induced by topical application of 5-aminolevulinic acid. In: Spinelli P, Dal Fante M, Marchesini R (eds) Photodynamic therapy and biomedical lasers. Elsevier, Milan, pp 449-453
61. Fritsch C, Stege H, Saalmann G, Goerz G, Ruzicka T, Krutmann J (1997) Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses. Photodermatol Photoimmunol Photomed 13:181-185
62. Morton CA, Whitehurst C, Moore JV, MacKie RM (2000) Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 143:767-772
63. Stringer MR (1995) Problems associated with the use of broadband illumination sources for photodynamic therapy. Phys Med Biol 40:1733-1735
64. Roberts F (1996) Comments on 'Problems associated with the use of broad-band illumination sources for photodynamic therapy'. Phys Med Biol 41:1517-1518
65. Kelleher DK, Thews O, Scherz A, Salomon Y, Vaupel P (2003) Combined hyperthermia and chlorophyll-based photodynamic therapy: tumour growth and metabolic microenvironment. Br J Cancer 89:2333-2339
66. Wilson BC, Patterson MS (1986) The physics of photodynamic therapy. Phys Med Biol 31:327-360